Treatment Options for Renal Cell Carcinoma: Mechanisms and Outcomes

نویسندگان

چکیده

Renal Cell Carcinoma (RCC), cancer of the tubules kidneys, has historically been one most difficult cancers to treat due its ability remain hidden in body for longer than other and tendency resist traditional forms chemotherapy radiation therapy. However, both nontraditional treatments RCC have seen significant biomedical advancements clinical instances use recent years. In this review, we analyze five RCC: Nephrectomy, Immunotherapy, Anti-Angiogenesis, Chemotherapy, Radiation Therapy, providing background on their mechanisms outcomes. Through our review studies outcomes, reaffirm existing thought that nephrectomy remains effective treatment RCC, while therapy are generally less not recommended own. Immunotherapy anti-angiogenic shown be modern healthcare landscape show great potential future as techniques better developed optimized.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Current and Future Treatment Options for Metastatic Renal Cell Carcinoma

Context: Metastatic renal cell carcinoma (mRCC) is associated with poor survival, and until recently, treatment options have been very limited. However, the advent of targeted therapies has radically improved the outlook for patients with mRCC. Objective: This review describes current treatment options for mRCC and summarizes the data on efficacy and safety of approved and newly emerging target...

متن کامل

New treatment options for metastatic renal cell carcinoma

During the last decade, the treatment of advanced or metastatic renal cell carcinoma (RCC) was revolutionised with the advent of antiangiogenic drugs and tyrosinekinase inhibitors. Several agents targeting the vascular endothelial growth factor (VEGF) pathway (sunitinib, bevacizumab, pazopanib, axitinib) or the mammalian target of rapamycin pathway (temsirolimus, everolimus) were since then pro...

متن کامل

Current Treatment Options for Disseminated Renal Cell Carcinoma

Renal cell carcinoma (RCC) is a common urologic tumor and accounts for about 3% of all human malignancies; its incidence has increased steadily in recent decades. Because 40–50% of all RCC patients present with or will develop metastasis, the annual mortality-to-incidence ratio with RCC is significantly higher compared with other urologic malignancies. Only recently, the discovery of specific g...

متن کامل

Treatment options in renal cell carcinoma: past, present and future.

Cytokine therapies have been the standard of care in metastatic renal cell carcinoma (RCC). However, these agents only provide clinical benefit to a small subset of patients and are associated with significant toxicity. A better understanding of the molecular biology of RCC has identified the vascular endothelial growth factor (VEGF) and platelet-derived growth factor signalling pathways as rat...

متن کامل

Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution.

Renal cell carcinoma (RCC) is more common in renal transplant and dialysis patients than the general population. However, RCC in transplanted kidneys is rare, and treatment has previously consisted of nephrectomy with a return to dialysis. There has been recent interest in nephron-sparing procedures as a treatment option for RCC in allograft kidneys in an effort to retain allograft function. Fo...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of urologic oncology

سال: 2023

ISSN: ['2617-7765', '2617-7773']

DOI: https://doi.org/10.32948/auo.2023.06.28